William P. Forbes

Insider Reports History

Location
Raleigh, NC
Signature
/s/ Kathryn Lester Attorney-in-Fact for William P. Forbes
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by William P. Forbes:

Company Role Class Num Shares Value Price $ Report Date Ownership
HERON THERAPEUTICS, INC. /DE/ EVP, Chief Development Officer Restricted Stock Units 30,994 $493,970 $2.64 19 Jan 2026 Direct
HERON THERAPEUTICS, INC. /DE/ EVP, Chief Development Officer Common Stock 170,078 $221,101 $1.30 19 Jan 2026 Direct
HERON THERAPEUTICS, INC. /DE/ EVP, Chief Development Officer Employee Stock Option (Right to Buy) 374,220 31 Jan 2025 Direct
Trevi Therapeutics, Inc. Chief Development Officer Stock Option (right to buy) 137,500 11 Feb 2022 Direct
Trevi Therapeutics, Inc. Chief Development Officer Performance Stock Options (right to buy) 48,000 29 Jun 2022 Direct
Beyond Air, Inc. Director Stock Options (Right to buy) 3,750 04 Nov 2025 Direct

Insider Reports Filed by William P. Forbes

Symbol Company Period Transactions Value $ Form Type Role Filing Time
HRTX HERON THERAPEUTICS, INC. /DE/ 19 Jan 2026 2 $0 4 EVP, Chief Development Officer 20 Jan 2026, 15:00
XAIR Beyond Air, Inc. 04 Nov 2025 16 $0 4 Director 06 Nov 2025, 21:45
HRTX HERON THERAPEUTICS, INC. /DE/ 31 Oct 2025 2 $0 4 EVP, Chief Development Officer 04 Nov 2025, 12:35
HRTX HERON THERAPEUTICS, INC. /DE/ 19 Oct 2025 2 $0 4 EVP, Chief Development Officer 21 Oct 2025, 11:56
HRTX HERON THERAPEUTICS, INC. /DE/ 31 Jul 2025 2 $0 4 EVP, Chief Development Officer 04 Aug 2025, 17:29
HRTX HERON THERAPEUTICS, INC. /DE/ 19 Jul 2025 2 $0 4 EVP, Chief Development Officer 22 Jul 2025, 12:43
HRTX HERON THERAPEUTICS, INC. /DE/ 06 Jun 2025 2 $0 4 EVP, Chief Development Officer 09 Jun 2025, 19:54
HRTX HERON THERAPEUTICS, INC. /DE/ 30 Apr 2025 2 $0 4 EVP, Chief Development Officer 02 May 2025, 20:41
HRTX HERON THERAPEUTICS, INC. /DE/ 19 Apr 2025 2 $0 4 EVP, Chief Development Officer 22 Apr 2025, 10:08
XAIR Beyond Air, Inc. 26 Mar 2025 1 $0 4 Director 28 Mar 2025, 17:12
HRTX HERON THERAPEUTICS, INC. /DE/ 31 Jan 2025 2 $0 4 EVP, Chief Development Officer 04 Feb 2025, 12:44
HRTX HERON THERAPEUTICS, INC. /DE/ 19 Jan 2025 2 $0 4 EVP, Chief Development Officer 22 Jan 2025, 09:15
XAIR Beyond Air, Inc. 22 Nov 2024 14 $0 4 Director 26 Nov 2024, 21:52
HRTX HERON THERAPEUTICS, INC. /DE/ 19 Oct 2024 2 $0 4 EVP, Chief Development Officer 21 Oct 2024, 15:53
HRTX HERON THERAPEUTICS, INC. /DE/ 19 Jul 2024 2 $0 4 EVP, Chief Development Officer 22 Jul 2024, 09:44
HRTX HERON THERAPEUTICS, INC. /DE/ 06 Jun 2024 2 $0 4 EVP, Chief Development Officer 07 Jun 2024, 09:34
HRTX HERON THERAPEUTICS, INC. /DE/ 19 Apr 2024 2 $0 4 EVP, Chief Development Officer 19 Apr 2024, 17:02
XAIR Beyond Air, Inc. 20 Mar 2024 1 $0 4 Director 21 Mar 2024, 21:01
HRTX HERON THERAPEUTICS, INC. /DE/ 19 Jan 2024 2 $0 4 EVP, Chief Development Officer 19 Jan 2024, 21:01
HRTX HERON THERAPEUTICS, INC. /DE/ 17 Nov 2023 1 +$27,250 4 EVP, Chief Development Officer 21 Nov 2023, 12:19
HRTX HERON THERAPEUTICS, INC. /DE/ 16 Nov 2023 1 +$46,995 4 EVP, Chief Development Officer 20 Nov 2023, 10:07
HRTX HERON THERAPEUTICS, INC. /DE/ 06 Jun 2023 0 $0 3 EVP, Chief Development Officer 12 Jun 2023, 16:41
XAIR Beyond Air, Inc. 31 Mar 2023 1 +$33,350 4 Director 03 Apr 2023, 16:15
XAIR Beyond Air, Inc. 29 Mar 2023 1 $0 4 Director 31 Mar 2023, 16:15
XAIR Beyond Air, Inc. 17 Mar 2023 1 +$32,300 4 Director 20 Mar 2023, 16:05
TRVI Trevi Therapeutics, Inc. 29 Jun 2022 1 $0 4 Chief Development Officer 01 Jul 2022, 16:49
XAIR Beyond Air, Inc. 03 Mar 2022 1 $0 4 Director 07 Mar 2022, 07:33
TRVI Trevi Therapeutics, Inc. 11 Feb 2022 1 $0 4/A Chief Development Officer 01 Jul 2022, 16:43